Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis

Status unconfirmed

Conditions studied: Rheumatoid Arthritis

In brief

The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on pain and functionality in people with rheumatoid arthritis (RA). SVF contains multiple cellular components, including stem cells, with both regenerative and anti-inflammatory properties. This therapy has shown promise for ameliorating the symptoms of RA. This study is designed to evaluate changes in pain and functionality in individuals with RA for up to 12 months following SVF treatment.

Key facts

Study ID

NCT02348086

Run by

StemGenex

People needed

50

Starts

2015-01-01

Expected to finish

2019-05-01

Last updated by the study team

2018-08-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects diagnosed with rheumatoid arthritis
• Subjects scheduled for a stem cell/SVF treatment
• Subjects willing and able to sign informed consent
• Subjects willing and able to perform follow-up interviews and surveys

You may not qualify if…

• Subjects with addition major health condition/disease diagnoses
• Subjects that are pregnant or breastfeeding

Where it is running

• StemGenex — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.